Hims & Hers Health, Inc.
$1.11B- Market cap
- $0.00
- Debt
- +$1.34B
- Cash
- −$228.62M
Capital structure 0% equity / 100% debt · EV / Revenue 0.47x · EV / EBITDA 7.55x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: HIMS stock price at premium vs INVH $27.91 current versus $15.06 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at INVH's multiple
Implied fair value · at HIMS's multiple
Snapshot Sep 8, 9:43 AM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple discount
Premium justified
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: HIMS FY 2025 (ended Dec 31, 2025) · INVH FY 2025 (ended Dec 31, 2025).
Trendline
Eight fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 0% equity / 100% debt · EV / Revenue 0.47x · EV / EBITDA 7.55x
Capital structure 67% equity / 33% debt · EV / Revenue 9.16x · EV / EBITDA 14.88x
INVH carries the larger enterprise value at $24.99B against $1.11B; HIMS trades on the lower EV / Revenue multiple (0.47x vs 9.16x); HIMS on the lower EV / EBITDA (7.55x vs 14.88x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
HIMS & HERS HEALTH, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Invitation Homes Inc. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
2.48x
0.88x
Net debt / EBITDA
Leverage against operating earnings
7.55x
4.91x
Cash and equivalents
Liquid reserves on the balance sheet
$228.62M
$129.97M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Teladoc Health, Inc.
HIMS vs TDOC
GoodRx Holdings, Inc.
HIMS vs GDRX
CLOVER HEALTH INVESTMENTS, CORP. /DE
HIMS vs CLOV
Roivant Sciences Ltd.
HIMS vs ROIV
American Homes 4 Rent
HIMS vs AMH
EQUITY RESIDENTIAL
HIMS vs EQR
AVALONBAY COMMUNITIES INC
HIMS vs AVB
UDR, Inc.
HIMS vs UDR
CAMDEN PROPERTY TRUST
HIMS vs CPT
$1.34B
$8.38B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.